Search for: "North American Medical Corp. v. Axiom Worldwide"
Results 1 - 15
of 15
Sorted by Relevance
|
Sort by Date
8 Apr 2008, 1:00 pm
By Eric Goldman North American Medical Corp. v. [read post]
10 Apr 2008, 7:22 am
North American Medical Corp. v. [read post]
31 Dec 2011, 3:11 pm
North American Medical Corp. v. [read post]
15 Mar 2013, 6:57 am
North American Medical Corp. v. [read post]
24 Apr 2008, 10:59 am
On April 7, 2008, in North American Medical Corp. v. [read post]
9 Apr 2008, 5:01 am
North American Medical Corp. v. [read post]
2 Jun 2014, 2:53 am
June 17, 2014 - 11 AM: North American Medical Corporation v. [read post]
26 May 2008, 6:02 pm
" Unlike some other courts that have reflexively found that use of a competitor's trademark in a megatag equals skewed search results equals infringement (such as the Eleventh Circuit in its recent decision in North American Medical Corp. v. [read post]
9 Apr 2008, 3:25 pm
Axiom Worldwide, Inc., No. 07-11574 (11th Cir. [read post]
18 Jul 2012, 11:59 pm
Dauben Inc., 324 Fed.Appx. 309, 318 n.13 (5th Cir. 2009) (same); North American Medical Corp. v. [read post]
19 Jul 2012, 6:59 am
Dauben Inc., 324 Fed.Appx. 309, 318 n.13 (5th Cir. 2009) (same); North American Medical Corp. v. [read post]
24 Feb 2016, 11:26 am
BPI argued that North American Medical Corp. v. [read post]
7 Jul 2008, 8:34 pm
North American Medical Corp. v. [read post]
18 Apr 2008, 2:00 am
: RealNetworks, Mattel and Hasbro copy the infringer by creating online Scrabble: (IP ThinkTank), Creative Commons Statement of Intent for Attribution-Share Alike Licenses released: (creativecommons.org) Events IP Business Congress – 25-26 June, Amsterdam: (IP Business Congress), INTA annual meeting – 17-21 May, Berlin: (IMPACT), Australia: IPRIA / CELRL / IP Australia: Employees’ IP and the employment relationship – incentives to innovate… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
